Testing effectiveness (Phase 2)Study completedNCT00637221
What this trial is testing
Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X Syndrome
Who this might be right for
Fragile X Syndrome
Neuropharm 12